Similar articles for PMID: 25742989

Year	Number of Results
1985	1
1987	1
2010	2
2011	2
2012	4
2013	6
2014	14
2015	17
2016	8
2017	8
2018	13
2019	21
2020	3
2024	0

1

We know now: Mavridis atrophy is associated with cognitive impairment in Parkinson disease.

Mavridis IN. Mavridis IN. AJNR Am J Neuroradiol. 2015 May;36(5):E38. doi: 10.3174/ajnr.A4315. Epub 2015 Mar 5. AJNR Am J Neuroradiol. 2015. PMID: 25742989 Free PMC article. No abstract available.

2

[Association of age-related white matter hyperintensity with brain atrophy and cognitive impairment in patients with Parkinson's disease].

Chen HM, Zhang MM, Wang YL. Chen HM, et al. Zhonghua Yi Xue Za Zhi. 2020 Nov 24;100(43):3397-3401. doi: 10.3760/cma.j.cn112137-20200519-01588. Zhonghua Yi Xue Za Zhi. 2020. PMID: 33238668 Chinese.

3

Depressive symptoms are associated with worse cognitive prognosis in patients with newly diagnosed idiopathic Parkinson disease.

Park JH, Lee SH, Kim Y, Park SW, Byeon GH, Jang JW; Parkinsons's Progression Marker Initiative. Park JH, et al. Psychogeriatrics. 2020 Nov;20(6):880-890. doi: 10.1111/psyg.12601. Epub 2020 Aug 24. Psychogeriatrics. 2020. PMID: 32840032

4

Clinically reliable cognitive decline in relapsing remitting multiple sclerosis: Is it the tip of the iceberg?

Andravizou A, Siokas V, Artemiadis A, Bakirtzis C, Aloizou AM, Grigoriadis N, Kosmidis MH, Nasios G, Messinis L, Hadjigeorgiou G, Dardiotis E, Peristeri E. Andravizou A, et al. Neurol Res. 2020 Jul;42(7):575-586. doi: 10.1080/01616412.2020.1761175. Epub 2020 May 19. Neurol Res. 2020. PMID: 32427076

5

The Role of Lysosomes in a Broad Disease-Modifying Approach Evaluated across Transgenic Mouse Models of Alzheimer's Disease and Parkinson's Disease and Models of Mild Cognitive Impairment.

Hwang J, Estick CM, Ikonne US, Butler D, Pait MC, Elliott LH, Ruiz S, Smith K, Rentschler KM, Mundell C, Almeida MF, Stumbling Bear N, Locklear JP, Abumohsen Y, Ivey CM, Farizatto KLG, Bahr BA. Hwang J, et al. Int J Mol Sci. 2019 Sep 9;20(18):4432. doi: 10.3390/ijms20184432. Int J Mol Sci. 2019. PMID: 31505809 Free PMC article.

6

Inner retinal thinning as a biomarker for cognitive impairment in de novo Parkinson's disease.

Sung MS, Choi SM, Kim J, Ha JY, Kim BC, Heo H, Park SW. Sung MS, et al. Sci Rep. 2019 Aug 14;9(1):11832. doi: 10.1038/s41598-019-48388-7. Sci Rep. 2019. PMID: 31413302 Free PMC article.

7

Magnetic Resonance Imaging-Visible Perivascular Spaces in Basal Ganglia Predict Cognitive Decline in Parkinson's Disease.

Park YW, Shin NY, Chung SJ, Kim J, Lim SM, Lee PH, Lee SK, Ahn KJ. Park YW, et al. Mov Disord. 2019 Nov;34(11):1672-1679. doi: 10.1002/mds.27798. Epub 2019 Jul 19. Mov Disord. 2019. PMID: 31322758

8

Structural Imaging in Parkinson's Disease: New Developments.

Prange S, Metereau E, Thobois S. Prange S, et al. Curr Neurol Neurosci Rep. 2019 Jun 18;19(8):50. doi: 10.1007/s11910-019-0964-5. Curr Neurol Neurosci Rep. 2019. PMID: 31214847 Review.

9

Pattern of cortical thinning associated with the BDNF Val66Met polymorphism in Parkinson's disease.

Sampedro F, Marín-Lahoz J, Martínez-Horta S, Pagonabarraga J, Kulisevsky J. Sampedro F, et al. Behav Brain Res. 2019 Oct 17;372:112039. doi: 10.1016/j.bbr.2019.112039. Epub 2019 Jun 13. Behav Brain Res. 2019. PMID: 31202861

10

Lower volume, more impairment: reduced cholinergic basal forebrain grey matter density is associated with impaired cognition in Parkinson disease.

Barrett MJ, Sperling SA, Blair JC, Freeman CS, Flanigan JL, Smolkin ME, Manning CA, Druzgal TJ. Barrett MJ, et al. J Neurol Neurosurg Psychiatry. 2019 Nov;90(11):1251-1256. doi: 10.1136/jnnp-2019-320450. Epub 2019 Jun 7. J Neurol Neurosurg Psychiatry. 2019. PMID: 31175168

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

81 results

Results by year